Recently diagnosed with HIV? Click here

New drug cures hard-to-treat hep C

Positive Living article • Adrian Ogier • 11 June 2010

In the trial, when the drug telaprevir was added to standard treatment with peginterferon alfa and ribavirinAn antiviral drug which is effective against a range of viruses including herpes, the hepatitis C virus and several strains of influenza. , about half of patients who had failed previous treatment with the two drugs cleared the virusA small infective organism which is incapable of reproducing outside a host cell..

The patients showed no evidence of HCVHepatitis C virus. infection six months after completing treatment, which is considered a cure.

Telaprevir is one of two highly anticipated drugs in the protease inhibitorA type of anti-HIV drug that works by preventing the production of an enzyme, protease, that HIV needs to replicate. class being studied in patients with chronic hepatitis C infection.

  • Delicious
  • Digg
  • StumbleUpon
  • Reddit
  • Facebook
  • Google
  • Yahoo
  • Technorati
Text size: font smallerfont normalfont larger print-friendly version of this pagePDF version of this pageemail this page to a friend

From Positive Living

This article was first published in the June 2010 issue of Positive Living — more than one year ago.

While the content of this was checked for accuracy at the time of publication, NAPWA recommends checking to determine whether the information is the most up-to-date available, especially when making decisions which may affect your health.

This article may contain medical information. NAPWA makes every reasonable effort to ensure the information on this website is accurate, reliable and up-to-date, including obtaining technical reviews by medically-qualified reviewers, however the authors of information on this website are not qualified to give medical advice, except where explicitly stated.

The content of this website is intended to support, not replace, the relationship between people living with HIV/AIDS and their medical advisers, and is not intended as a substitute for medical advice.

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.

more